Tara Mind, a Tysons, VA-based mental health company that enables safe and affordable access to psychedelic-assisted therapy (PAT), raised $3m in pre-seed funding.
Red Cell Partners made the investment.
The company intends to use the funds to expand its network of vetted PAT providers across the US and abroad and develop proprietary digital measurement-based care tools designed to ensure safety, optimize outcomes, and trigger early interventions when necessary.
Founded in 2022, Tara Mind is a Public Benefit Corporation that aims to expand access to psychedelic-assisted therapy (PAT). The company has built a network of vetted providers across the US and abroad to deliver PAT and is equipping them with proprietary digital measurement-based care tools that underpin the data-driven framework that supports value-based reimbursements for PAT by both employers and payors.
To further address issues of safety and efficacy, the company has codified The TARA Mind Way™, a set of standards established in partnership with clinicians to guarantee the availability of wraparound services for clients. This clinician-guided process – collectively known as PTIM™ – ensures that individuals who receive treatment through the TARA Mind Provider Network are receiving care that incorporates Preparation, Treatment, Integration, and Monitoring, the well-established hallmarks of effective and safe psychedelic treatment.
FinSMEs
13/04/2023